Literature DB >> 25337088

Cerebrospinal Venous Outflow in Multiple Sclerosis Patients versus Fatigue and/or Depression.

Marloes H J Hagens1, Erwin L J Hoogervorst1, Stephan T F M Frequin1, Selma C Tromp1.   

Abstract

BACKGROUND: Endovascular treatment of impaired cerebrospinal venous outflow has been suggested to improve the overall quality of life in multiple sclerosis (MS) patients. Fatigue and depression are key factors in measuring the quality of life in MS patients.
OBJECTIVE: In the present study, we investigated the correlation between anomalous venous outflow and the seriousness of fatigue and depression in MS patients and healthy controls.
METHODS: Five cerebrospinal venous outflow parameters were measured in 20 MS patients and age- and sex-matched controls using extra- and transcranial Colour Doppler sonography. All patients and volunteers filled out the Fatigue Severity Scale (FSS) and Hospital Anxiety Depression Subscale (HADS).
RESULTS: Nine abnormal parameters were found in 8 MS patients, whereas five abnormal parameters were found in 3 healthy controls (no significant difference). Only 1 MS patient met the criteria for chronic cerebrospinal venous insufficiency compared to 2 healthy controls. No significant differences were found in the FSS and HADS scores between patients with and without abnormal cerebrospinal venous outflow parameters.
CONCLUSIONS: We found no significantly impaired cerebrospinal venous outflow in patients with MS versus sex- and age-matched controls. Furthermore, we did not find any correlation between anxiety or depression and impaired venous outflow in MS patients.

Entities:  

Keywords:  Chronic cerebrospinal venous insufficiency; Colour Doppler sonography; Depression; Fatigue; Multiple sclerosis; Quality of life

Year:  2014        PMID: 25337088      PMCID: PMC4188158          DOI: 10.1159/000363070

Source DB:  PubMed          Journal:  Interv Neurol        ISSN: 1664-5545


  28 in total

Review 1.  Venous collateral circulation of the extracranial cerebrospinal outflow routes.

Authors:  Paolo Zamboni; Giuseppe Consorti; Roberto Galeotti; Sergio Gianesini; Erica Menegatti; Giovanna Tacconi; Francesco Carinci
Journal:  Curr Neurovasc Res       Date:  2009-08-01       Impact factor: 1.990

2.  Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study.

Authors:  G Comi; M A Battaglia; A Bertolotto; M Del Sette; A Ghezzi; G Malferrari; M Salvetti; M P Sormani; L Tesio; E Stolz; P Zaratin; G Mancardi
Journal:  Mult Scler       Date:  2013-09-06       Impact factor: 6.312

3.  Clinical aspects of fatigue in multiple sclerosis.

Authors:  R Bergamaschi; A Romani; M Versino; R Poli; V Cosi
Journal:  Funct Neurol       Date:  1997 Sep-Oct

4.  Progressive multiple sclerosis is not associated with chronic cerebrospinal venous insufficiency.

Authors:  C Baracchini; P Perini; F Causin; M Calabrese; F Rinaldi; P Gallo
Journal:  Neurology       Date:  2011-08-17       Impact factor: 9.910

5.  Symptomatic fatigue in multiple sclerosis.

Authors:  J E Freal; G H Kraft; J K Coryell
Journal:  Arch Phys Med Rehabil       Date:  1984-03       Impact factor: 3.966

Review 6.  Fatigue associated with multiple sclerosis: diagnosis, impact and management.

Authors:  Rohit Bakshi
Journal:  Mult Scler       Date:  2003-06       Impact factor: 6.312

7.  Chronic cerebrospinal venous insufficiency: case-control neurosonography results.

Authors:  Andrew D Barreto; Staley A Brod; Thanh-Tung Bui; James R Jemelka; Larry A Kramer; Kelly Ton; Alan M Cohen; John W Lindsey; Flavia Nelson; Ponnada A Narayana; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2013-02-26       Impact factor: 10.422

8.  Chronic cerebrospinal venous insufficiency is not associated with multiple sclerosis and its severity: a blind-verified study.

Authors:  Maurizio A Leone; Olga Raymkulova; Paola Naldi; Piergiorgio Lochner; Laura Bolamperti; Lorenzo Coppo; Alessandro Stecco; William Liboni
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

9.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

10.  A large-scale study of anxiety and depression in people with Multiple Sclerosis: a survey via the web portal of the UK MS Register.

Authors:  Kerina H Jones; David V Ford; Philip A Jones; Ann John; Rodden M Middleton; Hazel Lockhart-Jones; Lisa A Osborne; J Gareth Noble
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.